Scientific Fraud: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, First Session, on Apparent Wrongdoing at the NIH Laboratory of Tumor Cell Biology and Actions Involving the Office of Scientific Integrity, March 6 and August 1, 1991, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1992 - Law - 260 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
accused action ADAMSON allegations antibodies antigen ASTA Pharma believe BLILEY Cancer Institute Bethesda CHAFIN Chair Chairman CHASNOV Cleveland Clinic concern conduct confidentiality conflict of interest consulting CONTROL correct counsel D-Pen D-penicillamine D'AMico Degussa DEPARTMENT OF HEALTH Deputy DINGELL discussions DMSR documents draft report Drug fact FAES funded gentleman going grant application Hadley Hadley's Hallum HEALY hearing HYATT Imanishi-Kari immunofluorescence assay Institutes of Health involved Laboratory of Tumor LANMAN LENT Maryland Mason matter memo monoclonal antibodies National Cancer Institute National Institutes O'Toole Office of Scientific OSIR Pan Data patients Pfizer Placenta policies and procedures potential question RAUB recused Reponsif request Respondek responsibility Richards Panel ROWLAND Salahuddin Sarin SCHAEFER Schulof Scientific Integrity scientific misconduct scientist second inquiry signature signed staff statement Storb subcommittee tell Thank tion told Tumor Cell Biology virus weeks whistleblower